Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes. [PDF]
Diabetes Obes MetabHenney AE +6 more
europepmc +1 more source
Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. [PDF]
CureusAlsuwailem OA +7 more
europepmc +1 more source
GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk. [PDF]
Front Med (Lausanne)Ukwade D +11 more
europepmc +1 more source
Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy assisted weight loss: lessons from bariatric surgery. [PDF]
Int J Obes (Lond)Spreckley M, Ruggiero CF, Brown A.
europepmc +1 more source
Pros and Cons of Early Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors for Youth with Type 2 Diabetes: A Narrative Review. [PDF]
Diabetes TherDeLacey SE, Dieguez AC, Bensignor MO.
europepmc +1 more source
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning. [PDF]
Diabetes Metab JKim JA, Yoo HJ.
europepmc +1 more source
Association between GLP-1 receptor agonist use and substance use disorders among individuals with type 2 diabetes or obesity: a nested case-control study in the All of Us research program. [PDF]
Front PsychiatryAbegaz TM +3 more
europepmc +1 more source
iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China. [PDF]
Diabetes Obes MetabYu M.
europepmc +1 more source